Wintrust Financial Corporation »

Entrada Therapeutics shares owned by Wintrust Financial Corporation

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Wintrust Financial Corporation from 13F filings

Historical chart of Wintrust Financial Corporation investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Wintrust Financial Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Wintrust Financial Corporation

Quarter filed Position value Share count Share price at filing
2025-09-30 $238k 41k 5.80